-
Featured Press Release
Aspira Women’s Health Inc. Announcement New York State Medicaid Now Considers OVA1 Medically Necessary as of April 1, 2021
Learn More -
Partner Event
Join our President and CEO, Valerie Palmieri, March 17 at 12PM for a congressional briefing via to address Advancing Health Outcomes for Women and Minorities.
Register Here -
Women's History Month
We celebrate you. The unstoppable force. The midnight warrior. The barrier breakers and rule-makers. The listening ears and messy hands. The ones that make the world and then make it better. You are who we work for every day.
Read More
Press Release
Choose a Category:
-
Aspira Women’s Health Recognizes the Importance of Bridging the Gap in Ovarian Cancer Risk Assessment Disparities During Black History Month
Press Release
For a full pdf of this press release please click here AUSTIN, Texas — February 17, 2021- February is recognized as Black History Month, a time to honor the contributions of Black Americans to culture and society while elevating the voices of those fighting for equity and justice. This month, Aspira Women’s Health Inc. (Nasdaq:…
-
Aspira Women’s Health, Inc. to Participate in BTIG’s Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference
Press Release
AUSTIN, Texas — February 12, 2020 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced management will participate and present in the 2021 BTIG Virtual MedTech, Digital Health, Life Science and Diagnostic Tools Conference taking place on February 17-19. Details for the event are below: BTIG MedTech, Digital Health, Life…
-
Aspira Women’s Health, Inc. to add NCCN Management Recommendations to its Proprietary Aspira GenetiX Clinical Report
Press Release
Aspira will incorporate Management Recommendations from the National Comprehensive Cancer Network® (NCCN®) Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in the Aspira GenetiX report. For a pdf of this release please click here AUSTIN, Texas — February 10, 2021 — Aspira Women’s Health, Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced they will incorporate…
-
Aspira Women’s Health Inc. Announces Pricing of $45.0 Million Public Offering of Common Stock
Press Release
For a pdf of this press release please click here AUSTIN, Texas, February 4, 2021 – Aspira Women’s Health Inc. (Nasdaq: AWH) (“Aspira”), a bio-analytical based women’s health company focused on gynecologic disease, today announced the pricing of the previously announced underwritten public offering of 6,000,000 shares of its common stock at a price to…
-
Aspira Women’s Health Inc. Announces it is Now a Highmark Contracted Provider in Pennsylvania and West Virginia
Press Release
For a link to the pdf of this release please click here AUSTIN, Texas — January 28 — Aspira Women’s Health Inc. (Nasdaq: AWH), a bioanalytical-based women’s health company, today announced that it expanded access and has become a participating laboratory network provider, for all Pennsylvania and West Virginia commercial health insurance products of Highmark.…
Upcoming Events
-
April 30 – May 2, 2021
Virtual Exhibitor
American College of Obstetrics and Gynecologists Annual Meeting